• No results found

Off-Label Use of Recombinant Factor VIIa in Pediatric Patients

N/A
N/A
Protected

Academic year: 2020

Share "Off-Label Use of Recombinant Factor VIIa in Pediatric Patients"

Copied!
10
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

TABLE 1 Patient Demographics
FIGURE 1Clinical context by age group.
TABLE 2 Blood Products Administered in the 24 Hours Before and the 24 Hours AfterAdministration of First Dose of rFVIIa

References

Related documents

signs and symptoms are consistent with an altered mental status associated with a history of diabetes controlled by medication.. Ensure that the patient is responsive and able

Preoperative Modic changes are related to axial symptoms after anterior cervical discectomy and fusion.. Jiaming

In this process the content of secret message referred as plain text and by using different encryption.. algorithm cipher text is generated and after decryption

When we are entering in home the security system in enter the password we are entered correct password entering door will be opened and we are entered incorrect password the

After continuous administration of baicalin for 8 weeks, rotarod test and open fi eld test results in PD-treated groups were signi fi cantly improved, indicating that baicalin

and Hanaoka, F.: Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. and

The chapter examines the sense in which the experimenter is also a subject, the sense in which all experienced phenomena are private and subjective, the different senses in which

Fig. Costs are the biggest in the beginning of the project because of the signifi cant capital costs, mainly for cost of land and clearing. In the next two years, the annual costs